LEAH Labs
Human's best science for human's best friend 👨🏻🔬 🧬 🐶
Pitch Video
Investor Panel
Investor Panel
Luke interviewed LEAH Labs on March 30, 2021.
Play Video
Luke Iseman
Founder of boxouse, growerbot, Soil IQ, Dirtnail, and more. Former Director of Hardware at Y Combinator.
Strengths
says, "Wesley and team have a compelling plan to fight cancer in companion animals."
Advice
says, "Fleshing out more detail between now and 2024's therapy sales live could be compelling."
What Investors Say

What Friends Say

Jared FriedmanY Combinator Partner
LEAH Labs is doing real
breakthrough science. CAR-T therapy is the biggest breakthrough in cancer care in many years, and LEAH labs is the only company taking this technology that has cured many people and bringing it to the veterinary world. There are very few people in the world who have the right scientific experience needed to do this, and the LEAH labs team has some of the top scientists in the field working with them.

Joel HarrisCo-director of Ag Startup Engine
"It is an exciting time where we can bring novel, advance human health technology and apply it to the $70B+ Petcare space. We are excited to support Leah Labs and their efforts to cure cancer in dogs."

Tariq ShahA scientific and business consultant specifically within veterinary oncology
As a veterinary oncology consultant, I see first hand pet owner's desire to do and spend whatever necessary to keep their pets alive. CAR T technology is already proven in humans, and I think it has a bright future in the rapidly expanding companion animal medicine market. I think LEAH Labs has the technology and team to bring this breakthrough treatment to our pets!

Chand Khanna President, Ethos Discovery | C: 410-419-8542 | ethosvet.com
"LEAH Labs is bringing an innovative product to the growing field of canine oncology. In addition through their cross-species( dog-to-human) approach, their work has the potential to inform how cancer is treated in humans as well."

Barbara Beatty
Our angel group, FIN Capital, invested in LEAH Labs because we believe that dogs are part of the family, and that there is a huge market for breakthrough technology in the vet space.

Cassie EdgarBiotechnology Attorney & Advisor
LEAH Labs is not only doing good for doggos and their families...they have an exceptional use case for CRISPRs with a uniquely well positioned IP and regulatory pathway.
Wes and his team have hit the holy grail when it comes to gene editing: providing societal benefit, with a clear and streamlined path to commercialization compared to gene edited plants, livestock or human pharmaceutical applications.